必威体育_手机足球投注-官网app下载

图片

Organization / Member
Organization / Member

Member

Professor meeting

director
Masaharu Kawauchi (ADC Labs Professor/ Teikyo University General Medical Education and Research CenterProfessor)

Tamio TERAMOTO (ADC Lab. Professor / Teikyo Academic Research Center Head of Center)
Yusuke YOSHINO (ILCAA, Professor / School of Medicine Department of Microbiology Associate Professor)
Yasushi Furukawa (ILCAA Professor / School of Medicine Laboratory Medicine Professor)
Toshihiro HAYASHI (ILCAA Professor / School of Medicine Department of Physiology Professor)
SEN TAKEDA (ILCAA Professor / School of Medicine Department of Anatomy Professor)
Yasuhiro OHTAKI (ILCAA Professor / Teikyo University General Medical Education and Research Center Professor)
Jun YAMASHITA (ILCAA Professor / Faculty of Pharmaceutical Sciences Laboratory of Life Science and Pharmacology Professor)
Naohisa Matsunaga (ILCAA Associate Professor / School of Medicine Affiliated Hospital Department of Infection Control and Prevention Director)
Mariko INOUE (ILCAA Associate Professor / Graduate School Graduate School of Public Health Associate Professor)
Shoichi SUZUKI (ILCAA Associate Professor / Teikyo University General Medical Education and Research Center Associate Professor)
Takeshi Yamada (ILCAA, Associate Professor / Medical Mycology Research Center, Associate Professor)
Kazuhiro Takahashi (ILCAA, Senior Assistant Professor / School of Medicine Hospital Pediatrics Senior Assistant Professor)
Ryuichi Sugamata (ILCAA, Senior Assistant Professor / Teikyo University General Medical Education and Research Center Senior Assistant Professor)
Shigehiro TOHKAI (ILCAA Assistant Professor / School of Medicine Hospital Pediatrics Assistant Professor)
Suiyu Ito (ILCAA, Assistant Professor / Teikyo University General Medical Education and Research Center Assistant Professor)

Yutaka Tonegawa (Secretariat / Secretary General, General Affairs Department, Itabashi Campus, Teikyo University)

observer
Keizo Inoue (Vice President)

Steering committee member

School of Medicine the greatest of all
Faculty of Pharmaceutical Sciences the greatest of all
Faculty of Medical Technology the greatest of all
Graduate School of Medicine the greatest of all
Graduate School of Pharmaceutical Sciences the greatest of all
Graduate School of Medical Care and Technology the greatest of all
Graduate School of Public Health the greatest of all
School of Medicine affiliated hospital director
Teikyo University General Medical Education and Research Center the greatest of all
Teikyo Academic Research Center the greatest of all
Faculty members appointed by each dean and the head of each Dean or other department
Staff at the University's headquarters and at Itabashi Campus Office
12 extramural committee members (staff from National Institute of Infectious Diseases, National Center for Global Health and Medicine, National Institute of Tuberculosis Research, Institute of Medical Science, University of Tokyo, Kitasato Institute, etc.)

(As of April 2021)

Organization / system diagram

感染症研究部門

Organizational structure of the infectious disease research department

In order to prevent respiratory tract infections, which are a threat in Asia and other countries, we will promote research and education related to infectious disease control from a global perspective, and through international exchanges on infectious disease control in Asia. Contributes to global health.

Infectious Diseases Unit

  • Promote research on infectious disease control
  • Research and research on infectious disease control mainly in Asia
  • Promotion of researches associated with prevention / control of infectious diseases
  • Assessment and investigation of pathogenic disease control in Asian countries

Infectious Disease Laboratory

Chief: Senior Assistant Professor Ryuichi Sugamata
Lab Chief: Ryuichi Sugamata Ph.D.

  • Study on the pathogenic mechanism of severe pneumonia caused by influenza virus infection
  • Screening of new drugs with therapeutic effects or repositioning of existing drugs with the aim of developing new therapeutic drugs for influenza infections
  • Elucidation of the mechanism of suppression of influenza virus activity due to the special efficacy of macrolide drugs
  • Research for pathogenesis of severe / fulminant viral pneumonia induced by influenza virus
  • Development and / or repositioning of novel effective anti-influenza agents
  • Study of the mechanism anti-influenza virus activities by macrolide derivatives

Laboratory of Host-defense

Chief: Shoichi Suzuki Associate Professor
Lab Chief: Associate Prof. Shoichi Suzuki

  • Analysis of biological defense function in the respiratory tract due to influenza virus infection
  • Role of HOSCN produced in lung epithelial cells and biological defense
  • Host-defense activity on influenza virus infection into airway in lung
  • Role of HOSCN produced from lung epitherial cells in host-defense

Organizational structure of the infectious disease research department

ステムセル治療コンソーシアムブランチ

Organizational structure of stem cell treatment consortium branch

Stem Cell Therapy Consortium (SCTC) Branch

We agree with our faculty and staff to determine the research and clinical policy from the basic to clinical treatment of Stem Cell Transplantation (hereinafter referred to as "SCT") and to contribute to the control and treatment of intractable diseases. The purpose is to contribute to the advancement of medicine and medical health by doctors and researchers.

[Member] ADC SCTC Branch [Organization]

Masaharu Kawachi Branch Head, Director of ADC Labs
Masakazu Mimaki Professor Pediatrics School of Medicine
Yasushi KishimotoProfessor, Faculty of Pharmaceutical Sciences Professor Department of Pharmaceutical Sciences
Noboru Yoshioka, Senior Assistant Professor in Physiology School of Medicine Medicine
Haruko Tashiro Senior Assistant Professor School of Medicine Internal Medicine Medicine (Internal Medicine), Faculty of Medicine
Fukiyu Ito ADC research Assistant Professor
Tamio Teramoto, Head of Center TARC and Advisor

ADC Labs Visiting Professor
Tokiko Nagamura, Director, Cell Processing and Transfusion Department, University Hospital, Institute of Medical Science, The University of Tokyo
OIZAWA Keiya Jichi Medical University Immunogene Cell Therapeutics Visiting Professor
HARADA Hironori Oncology Laboratory, Department of Biomedical Sciences, Faculty of Life Sciences, Tokyo University of Pharmaceutical Sciences Professor
Teruyo Arato, Hokkaido University Clinical Research and Development Center Professor
Tomio Okazaki Facility Manager of Severely Mentally and Physically Severe Facility "Tokiwa Kure"
Hiroyuki Fui, Severely Mentally and Physically Ill Facility, Aisenkai Ninan Hospital, Hospital Director

Advisor
Atsushi Iwama Professor, Stem Cell Molecular Medicine, Institute of Medical Science, University of Tokyo

Vietnam
Vinmec Research Institute of Stem Cell and Gene Technology (Vinmec International Hospital Nguyen Thanh Liem, Director)

usa
NIH / NIAID
Harry Malech: [Chief] Genetic Immunotherapy Section, [Deputy Chief] Laboratory of Clinical Immunology and Microbiology

NIH / NICHD
Keiko Ozato: [Chief] SMGI, DDB

Organizational structure of stem cell treatment consortium branch